Standout Papers

Investigating the replicability of preclinical cancer biology 2021 2026 2022 2024152
  1. Investigating the replicability of preclinical cancer biology (2021)
    Timothy M. Errington, Maya B. Mathur et al. eLife

Immediate Impact

1 from Science/Nature 55 standout
Sub-graph 1 of 23

Citing Papers

Data leakage inflates prediction performance in connectome-based machine learning models
2024 Standout
Fusobacterium nucleatum promotes tumor progression in KRAS p.G12D-mutant colorectal cancer by binding to DHX15
2024 Standout
2 intermediate papers

Works of Nicole Perfito being referenced

Investigating the replicability of preclinical cancer biology
2021 Standout
Replication Study: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
2018

Author Peers

Author Last Decade Papers Cites
Nicole Perfito 901 643 245 445 60 1.8k
Arthur Goldsmith 1151 804 291 157 36 1.8k
B. Lofts 690 789 35 536 79 2.1k
Nancy M. Czekala 585 718 161 563 74 2.6k
Yuichi Tanabe 408 305 104 296 124 2.7k
Andrew E. Fidler 390 410 57 163 56 1.9k
J.L. Silsby 300 171 51 686 56 1.5k
Matthew B. Lovern 1143 477 67 78 51 1.7k
Katharina Foerster 1266 616 221 40 60 2.3k
U. S. Seal 283 906 17 287 84 2.3k
Geert R. Verheyen 1062 751 200 40 83 2.7k

All Works

Loading papers...

Rankless by CCL
2026